Recent Developments in the Treatment of Bladder Cancer

作者: Raymond S. Lance , H. Barton Grossman

DOI: 10.1007/978-1-4419-8889-8_1

关键词:

摘要: Transitional cell carcinoma of the bladder (TCC) is a significant cause suffering and death. It estimated that 53,200 persons will be diagnosed with TCC 12,200 die this disease in United States 2000.13 Though majority people have superficial disease, most who cancer present invasive disease.19 Although patients experience recurrence rates as high 82%, rate progression to muscle-invasive or metastasis only 10 15%.18

参考文章(59)
Eila Skinner, Donald G. Skinner, Seth P. Lerner, Radical cystectomy in regionally advanced bladder cancer. Urologic Clinics of North America. ,vol. 19, pp. 713- 723 ,(1992) , 10.1016/S0094-0143(21)00442-0
Douglas E. Coplen, Michael D. Marcus, Joseph A. Myers, Timothy L. Ratliff, William J. Catalona, Long-Term Followup of Patients Treated With 1 or 2, 6-Week Courses of Intravesical Bacillus Calmette-Guerin: Analysis of Possible Predictors of Response Free of Tumor Journal of Urology. ,vol. 144, pp. 652- 657 ,(1990) , 10.1016/S0022-5347(17)39546-0
J.M. Fitzpatrick, A.B. West, M.R. Butler, V. Lane, J.D. O’Flynn, Superficial Bladder Tumors (Stage pTa, Grades 1 and 2): The Importance of Recurrence Pattern Following Initial Resection The Journal of Urology. ,vol. 135, pp. 920- 922 ,(1986) , 10.1016/S0022-5347(17)45923-4
Carlos Cordon-Cardo, Victor E. Reuter, Guido Dalbagni, Elizabeth Charytonowicz, Maria Drobnjak, Zuo Feng Zhang, Hong Ji Xu, William F. Benedict, Shi Xue Hu, Cooperative Effects of p53 and pRB Alterations in Primary Superficial Bladder Tumors Cancer Research. ,vol. 57, pp. 1217- 1221 ,(1997)
Sauter G, Guoren Deng, Holger Moch, Russell Kerschmann, Kouji Matsumura, Sandy De Vries, Tracy George, Jose Fuentes, Peter Carroll, Michael J Mihatsch, Frederic M Waldman, Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. American Journal of Pathology. ,vol. 144, pp. 756- 766 ,(1994)
M. Antelo, J. L. Palmer, C. P. N. Dinney, W. F. Benedict, S.-X. Hu, M. Liebert, H. B. Grossman, p53 and RB expression predict progression in T1 bladder cancer. Clinical Cancer Research. ,vol. 4, pp. 829- 834 ,(1998)
B L Bane, R E Hurst, G P Hemstreet, R B Bonner, M Liebert, H B Grossman, Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 5, pp. 971- 978 ,(1996)
Christophe E. Iselin, Cary N. Robertson, George D. Webster, Johannes Vieweg, David F. Paulson, DOES PROSTATE TRANSITIONAL CELL CARCINOMA PRECLUDE ORTHOTOPIC BLADDER RECONSTRUCTION AFTER RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER The Journal of Urology. ,vol. 158, pp. 2123- 2126 ,(1997) , 10.1016/S0022-5347(01)68174-6
Michael Stockle, Walter Meyenburg, Stefan Wellek, Gunther E. Voges, Mithra Rossmann, Ulrich Gertenbach, Joachim W. Thuroff, Christian Huber, Rudolf. Hohenfellner, Adjuvant Polychemotherapy of Nonorgan-Confined Bladder Cancer After Radical Cystectomy Revisited: Long-Term Results of a Controlled Prospective Study and Further Clinical Experience The Journal of Urology. ,vol. 153, pp. 47- 52 ,(1995) , 10.1097/00005392-199501000-00019
B.S. Schmetter, K.K. Habicht, D.L. Lamm, A. Morales, N.H. Bander, H.B. Grossman, M.G. Hanna, S.R. Silberman, B.T. Butman, A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer Journal of Urology. ,vol. 158, pp. 801- 805 ,(1997) , 10.1016/S0022-5347(01)64321-0